Never Event First- Pass effect Therapeutic index Antagonistic effects Free! Normal BUN Caring Onset of action Peak and Trough levels Informatics Additive effects Half- life Loading dose Pharmacokinetics Therapeutic effect Pharmacodynamics Normal GFR Therapeutic classification Quality improvement Patient- Centered care Incompatible Evidence- based practice Sensoristasis National Patient Safety Goal Synergistic effects Always Event Efficacy Systematic review Potency HIPAA Bioavailability Quality assurance Duration of action Agonist drug Sensory Perception Metabolism RACE Peak action Pharmacologic classification Side effect Normal ALT Antagonist drug PICO Adverse effect The Joint Commission Never Event First- Pass effect Therapeutic index Antagonistic effects Free! Normal BUN Caring Onset of action Peak and Trough levels Informatics Additive effects Half- life Loading dose Pharmacokinetics Therapeutic effect Pharmacodynamics Normal GFR Therapeutic classification Quality improvement Patient- Centered care Incompatible Evidence- based practice Sensoristasis National Patient Safety Goal Synergistic effects Always Event Efficacy Systematic review Potency HIPAA Bioavailability Quality assurance Duration of action Agonist drug Sensory Perception Metabolism RACE Peak action Pharmacologic classification Side effect Normal ALT Antagonist drug PICO Adverse effect The Joint Commission
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Never Event
First-Pass effect
Therapeutic index
Antagonistic effects
Free!
Normal BUN
Caring
Onset of action
Peak and Trough levels
Informatics
Additive effects
Half-life
Loading dose
Pharmacokinetics
Therapeutic effect
Pharmacodynamics
Normal GFR
Therapeutic classification
Quality improvement
Patient-Centered care
Incompatible
Evidence-based practice
Sensoristasis
National Patient Safety Goal
Synergistic effects
Always Event
Efficacy
Systematic review
Potency
HIPAA
Bioavailability
Quality assurance
Duration of action
Agonist drug
Sensory Perception
Metabolism
RACE
Peak action
Pharmacologic classification
Side effect
Normal ALT
Antagonist drug
PICO
Adverse effect
The Joint Commission